Evaluation of In vivo Bioactivity of a Mutated Streptokinase

Evaluation of In vivo Bioactivity of a Mutated Streptokinase

<br /><p> </p><h2>Background: Immunogenicity of Streptokinase, as a thrombolytic drug, has limited its clinical use. Elimination of the amino acid residues that are responsible for immunogenicity while don’t affect the bioactivity of streptokinase is worthy. Recently, we modi...

Full description

Bibliographic Details
Main Authors: Marzieh Sameni, Mazaher Gholipourmalekabadi, Mojgan Bandehpour, Mehrdad Hashemi, Farzin Sahebjam, V Tohidi, Bahram Kazemi
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2017-04-01
Series:Novelty in Biomedicine
Subjects:
Thrombolysis
Recombinant streptokinase
Thrombolytic agent
Fibrinolytic activity
Jugular vein
Clot formation
Online Access:http://journals.sbmu.ac.ir/nbm/article/view/13694

Internet

http://journals.sbmu.ac.ir/nbm/article/view/13694

Similar Items